A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior

Journal of Pharmacological and Toxicological Methods

Volumn 59, Issue 3, 2009, Pages 141-145

  Flaisher Grinberg, Shlomit ^a   Einat, Haim ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Affective disorders; Animal models; Bipolar disorder; Endophenotypes; Mania; Methods; Mice; Mood stabilizers; Predictive validity

Indexed keywords

IMIPRAMINE; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE MODEL; FORCED SWIMMING TEST; GOAL ATTAINMENT; HETEROSIS; MALE; MANIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DOMAIN;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; IMIPRAMINE; IMMOBILIZATION; MICE; STRESS, PSYCHOLOGICAL; VALPROIC ACID;

ANIMALIA; MUS;

EID: 67349149010     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2009.03.003     Document Type: Article

References (58)

1. Abler B., Greenhouse I., Ongur D., Walter H., and Heckers S. Abnormal reward system activation in mania. Neuropsychopharmacology 33 (2008) 2217-2227
2. Abramov U., Puussaar T., Raud S., Kurrikoff K., and Vasar E. Behavioural differences between C57BL/6 and 129S6/SvEv strains are reinforced by environmental enrichment. Neuroscience Letters. 443 (2008) 223-227
3. Bai F., Li X., Clay M., Lindstrom T., and Skolnick P. Intra- and interstrain differences in models of "behavioral despair". Pharmacology, Biochemistry and Behavior 70 (2001) 187-192
4. Benazzi F. Bipolar II disorder: Epidemiology, diagnosis and management. CNS Drugs. 21 (2007) 727-740
5. Bersudsky Y., Shaldubina A., and Belmaker R.H. Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behavioral Pharmacology 18 (2007) 77-80
6. Bourin M., Chenu F., Ripoll N., and David D.J. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behavioral Brain Research 164 (2005) 266-269
7. Bourin M., Hascoet M., Colombel M.C., Redrobe J.P., and Baker G.B. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: Possible roles of serotoninergic systems. European Neuropsychopharmacology 6 (1996) 231-236
8. Bourin M., Redrobe J.P., Hascoet M., Baker G.B., and Colombel M.C. A schematic representation of the psychopharmacological profile of antidepressants. Progress in Neuropsychopharmacology Biology and Psychiatry 20 (1996) 1389-1402
9. Cleary C., Linde J.A., Hiscock K.M., Hadas I., Belmaker R.H., Agam G., et al. Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Research Bulletin 76 (2008) 469-473
10. Crawley J.N. Behavioral neuroscience. In: Crawley J.N., and McKay J. (Eds). Current protocols in neuroscience (2007), Wiley Interscience, New York
11. Cryan J.F., and Slattery D.A. Animal models of mood disorders: Recent developments. Current Opinion in Psychiatry. 20 (2007) 1-7
12. Dsm-IV (2000). Diagnostic and statistical manual of mental disorders, IV-TR edn. American Psychiatric Association, American Psychiatric Association.
13. Einat H. Modelling facets of mania-New directions related to the notion of endophenotypes. Journal of Psychopharmacology 20 (2006) 714-722 Electronic publication 2006 Jan 9
14. Einat H. Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders. Phytotherahy Research 21 (2007) 62-66
15. Einat H. Different behaviors and different strains: Potential new ways to model bipolar disorder. Neurosciece and Biobehavioral Reviews 31 (2007) 850-857
16. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: A practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behavioral Genetics 37 (2007) 244-255
17. Einat H., Clenet F., Shaldubina A., Belmaker R.H., and Bourin M. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behavioral Brain Research 118 (2001) 77-83
18. Einat H., Karbovski H., Korik J., Tsalah D., and Belmaker R.H. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology (Berl) 144 (1999) 158-162
19. Einat H., Shaldubina A., Bersudskey Y., and Belmaker R.H. Prospects for the development of animal models for the study of bipolar disorder. In: Soares J.C., and Young A. (Eds). Bipolar disorders: Basic mechanisms and therapeutic implications (2007), Taylor & Francis, New York
20. Einat H., Yuan P., and Manji H.K. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders. Behavioral Brain Research 165 (2005) 172-180
21. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., et al. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Molecular Psychiatry 29 (2008) 29
22. Flaisher-Grinberg S., Kronfeld-Schor N., and Einat H. Models of mania: From facets to domains and from animal models to model animals. Journal of Psychopharmacology 6 (2008) 6
23. Flaisher-Grinberg S., Overgaard S., and Einat H. Strain-specific battery of tests for manic-like behavior in mice: Implications for model development. Biological Psychiatry 63 (2008) 64S
24. Flaisher-Grinberg S., Overgaard S., and Einat H. Attenuation of high sweet solution preference by mood stabilizers: A possible mouse model for the increased reward-seeking domain of mania. Journal of Neuroscience Methods 177 (2009) 44-50
25. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry 160 (2003) 636-645
26. Gould T.D., and Einat H. Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement. Neuroscience Biobehavioral Reviews 31 (2007) 825-831
27. Gould T.D., Einat H., Bhat R., and Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. International Journal Neuropsychopharmacology 7 (2004) 387-390
28. Gould T.D., and Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behavior 5 (2006) 113-119
29. Gould T.D., O Donnell K.C., Picchini A.M., and Manji H.K. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: A mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32 (2007) 1321-1333
30. Hasler G., Drevets W.C., Gould T.D., Gottesman I.I., and Manji H.K. Toward constructing an endophenotype strategy for bipolar disorders. Biological Psychiatry 60 (2006) 93-105
31. Hiscock K., Linde J., and Einat H. Black Swiss mice as a new animal model for mania: A preliminary study. Journal of Medical and Biological Sciences 1 (2007) 2
32. Johnson S.L. Mania and dysregulation in goal pursuit: A review. Clinical Psychological Review 25 (2005) 241-262
33. Karolewicz B., Paul I.A., and Antkiewicz-Michaluk L. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Polish Journal of Pharmacology 53 (2001) 587-596
34. Khisti R.T., and Chopde C.T. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Research 865 (2000) 291-300
35. Kochanowska A.J., Rao K.V., Childress S., El-Alfy A., Matsumoto R.R., Kelly M., et al. Secondary metabolites from three Florida sponges with antidepressant activity. Journal of Natural Products 71 (2008) 186-189
36. Kroczka B., Branski P., Palucha A., Pilc A., and Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Research Bulletin 55 (2001) 297-300
37. Lerman I., Harrison B.C., Freeman K., Hewett T.E., Allen D.L., Robbins J., et al. Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. Journal of Applied Physiology 92 (2002) 2245-2255
38. Loftus S.T., Garno J.L., Jaeger J., and Malhotra A.K. Temperament and character dimensions in bipolar I disorder: A comparison to healthy controls. Journal of Psychiatric Research 42 (2008) 1131-1136
39. Lucki I., Dalvi A., and Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl). 155 (2001) 315-322
40. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., and Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. Journal of Neuroscience 28 (2008) 3071-3075
41. Maremmani I., Akiskal H.S., Signoretta S., Liguori A., Perugi G., and Cloninger R. The relationship of Kraepelian affective temperaments (as measured by TEMPS-I) to the tridimensional personality questionnaire (TPQ). Journal of Affective Disorders 85 (2005) 17-27
42. Monleon S., D Aquila P., Parra A., Simon V.M., Brain P.F., and Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl) 117 (1995) 453-457
43. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., et al. Preclinical models: Status of basic research in depression. Biological Psychiatry 52 (2002) 503-528
44. O Brien W.T., Harper A.D., Jove F., Woodgett J.R., Maretto S., Piccolo S., et al. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. Journal of Neuroscience 24 (2004) 6791-6798
45. Popik P., Kos T., Sowa-Kucma M., and Nowak G. Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology (Berl). 198 (2008) 421-430
46. Porsolt R.D., Bertin A., and Jalfre M. "Behavioural despair" in rats and mice: Strain differences and the effects of imipramine. Europian Journal of Pharmacology 51 (1978) 291-294
47. Porsolt R.D., Brossard G., Hautbois C., and Roux S. Rodent models of depression: Forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci (2001) Chapter: Unit 8.10A
48. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
49. Redrobe J.P., MacSweeney C.P., and Bourin M. The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Europian Journal of Pharmacology 318 (1996) 213-220
50. Sadock J., and Kaplan H. Synopsis of psychiatry. 9 edn (2002), Lippincott & Williams
51. Sanchez C., and Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?. Psychopharmacology (Berl) 129 (1997) 197-205
52. Stahl S.M. Essential psychopharmacology. Neuroscientific Basis and Practical Application. 3rd edn (2008), Cambridge University Press, Cambridge, UK
53. Tecott L.H., and Nestler E.J. Neurobehavioral assessment in the information age. Nature Neuroscience 7 (2004) 462-466
54. Thase M.E., and Denko T. Pharmacotherapy of mood disorders. Annual Revew of Clinical Psychology 4 (2008) 53-91
55. Whirley B.K., and Einat H. Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. Israel Journal of Psychiatry and Related Sciences 45 (2008) 11-18
56. Willner P. Animal models as simulations of depression. Trends in Pharmacology Sciences 12 (1991) 131-136
57. Wiste A.K., Arango V., Ellis S.P., Mann J.J., and Underwood M.D. Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder. Bipolar Disorders 10 (2008) 349-359
58. Yoshikawa T., Watanabe A., Ishitsuka Y., Nakaya A., and Nakatani N. Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. Genome Research 12 (2002) 357-366